This document discusses mesenteric ischemia, including:
1. It describes the different types of mesenteric ischemia such as occlusive arterial disease, mesenteric venous thrombosis, and non-occlusive mesenteric ischemia.
2. The pathophysiology and causes of altered mesenteric circulation are explained, noting that prolonged ischemia can lead to vasoconstriction.
3. Features of obtaining a history and physical exam for acute vs chronic mesenteric ischemia are provided, highlighting important clues for diagnosis.
MESENTERIC ISCHEMIA- GENERALISED ABDOMINAL PAIN
#surgicaleducator #epigastricabdominalpain #pepticulcerdisease #usmle #babysurgeon #surgicaltutor
• Dear Viewers,
• Greetings from “Surgical Educator”
• Today I have uploaded a video on Mesenteric Ischemia- a didactic lecture.
• It is one of the uncommon but life-threatening surgical problems you see in surgical wards.
• I have discussed the various causes for Generalised Abdominal Pain, epidemiology, etiology, pathology, clinical features, investigations, and treatment of Mesenteric Ischemia.
• I have also included a mind map and a treatment algorithm for Mesenteric Ischemia.
• I hope the video will be very useful and you will enjoy it.
• You can watch all my surgical teaching videos in the following link:
• youtube.com/c/surgicaleducator
• Thank you for watching the video.
MESENTERIC ISCHEMIA- GENERALISED ABDOMINAL PAIN
#surgicaleducator #epigastricabdominalpain #pepticulcerdisease #usmle #babysurgeon #surgicaltutor
• Dear Viewers,
• Greetings from “Surgical Educator”
• Today I have uploaded a video on Mesenteric Ischemia- a didactic lecture.
• It is one of the uncommon but life-threatening surgical problems you see in surgical wards.
• I have discussed the various causes for Generalised Abdominal Pain, epidemiology, etiology, pathology, clinical features, investigations, and treatment of Mesenteric Ischemia.
• I have also included a mind map and a treatment algorithm for Mesenteric Ischemia.
• I hope the video will be very useful and you will enjoy it.
• You can watch all my surgical teaching videos in the following link:
• youtube.com/c/surgicaleducator
• Thank you for watching the video.
in this presentation me & my colleagues discuss briefly the types of mesenteric ischemia ( acute , chronic , venous ) and its related syndromes (superior mesenteric artery syndrome , celiac trunk syndrome and supply it by good radiologic images ..
Brief description on the benign tumors of liver that includes hemangioma, focal nodular hyperplasia, regenerative nodular hyperplasia, dysplastic foci, dysplastic nodules and focal fatty change.
pancreatic injury is very common in case of road traffic accident and it needs to be evaluated promptly and decision to be taken as early aas possible .this presentation will give an overview of pancreatic injury management.
GEMC: Mesenteric Ischemia: Resident Training Open.Michigan
This is a lecture by Dr. Andrew Barnosky from the Ghana Emergency Medicine Collaborative. To download the editable version (in PPT), to access additional learning modules, or to learn more about the project, see http://openmi.ch/em-gemc. Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: http://creativecommons.org/licenses/by-sa/3.0/.
in this presentation me & my colleagues discuss briefly the types of mesenteric ischemia ( acute , chronic , venous ) and its related syndromes (superior mesenteric artery syndrome , celiac trunk syndrome and supply it by good radiologic images ..
Brief description on the benign tumors of liver that includes hemangioma, focal nodular hyperplasia, regenerative nodular hyperplasia, dysplastic foci, dysplastic nodules and focal fatty change.
pancreatic injury is very common in case of road traffic accident and it needs to be evaluated promptly and decision to be taken as early aas possible .this presentation will give an overview of pancreatic injury management.
GEMC: Mesenteric Ischemia: Resident Training Open.Michigan
This is a lecture by Dr. Andrew Barnosky from the Ghana Emergency Medicine Collaborative. To download the editable version (in PPT), to access additional learning modules, or to learn more about the project, see http://openmi.ch/em-gemc. Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: http://creativecommons.org/licenses/by-sa/3.0/.
ascites is a major complication of liver cirrhsos but also develops as a squally of other diseases ,ascites may be worsened with other events making it life threatening
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
2. BO5:1
• 1. Abdominal pain due to mesenteric ischemia is
• A. Rare.
• B. Uncommon.
• C. Common.
• D. Very common.
• E. Not uncommon.
3. BO5:2
• 2. The mortality from acute mesenteric ischemia is:
• A. Rare.
• B. Uncommon.
• C. Common.
• D. Very common.
• E. Not uncommon.
4. BO5:3
• 3. The most common cause of mesenteric ischemia is:
• A. Acute throbosis.
• B. Acute embolism.
• C. Acute dissection.
• D. Chronic atherosclerotic occlusion.
• E. Venous thrombosis.
5. BO5:4
• 4. The sequence of events in pathophysiology of acute mesenteric
ischemia include all except:
• A. Initial Vasospasm.
• B. Intestinal bacterial translocation.
• C. Systemic inflammatory response.
• D. Vasoconstriction.
• E. Intestinal infarction.
6. BO5:5
• 5. Mesenteric ischemia differs from other major organs
atherosclerotic ischemias by being:
• A. More common.
• B. Less lethal.
• C. More common in females.
• D. Easier to be diagnosis.
• E. All of the above.
7. BO5:6
• 6. The abdominal pain of acute mesenteric ischemia have more
similar characteristics to:
• A. Acute appendisitis.
• B. Acute cholecystitis.
• C. Acute pancreatitis.
• D. Bud-Chiari syndrome.
• E. Splenic infarction.
8. BO5:7
• 7. The abdominal pain of acute mesenteric ischemia is characterized
by being:
• A. Proportional to physical findings.
• B. Out of proportion to physical findings.
• C. Aggravated by movements.
• D. Relieved by movements.
• E. Associated with fever.
9. BO5:8
• 8. Clues to acute mesenteric ischemia as a cause of acute abdominal
pain is the presence of:
• A. DVT.
• B. Recent abdominal surgery.
• C. AF &AMI.
• D. Presence of diagnosed thrombophilia.
• E. Male sex.
10. BO5:9
• 9. Clues to the chronic mesenteric ischemia as a cause of chronic
abdominal pain is the presence of all except:
• A. Immediate post-prandial pain.
• B. 30 mins post-prandial pain.
• C. Food fear.
• D. Weight loss.
• E. Female sex.
11. BO5:10
• 10. The serum marker suggesting severe acute mesenteric ischemia
is:
• A. Albumin.
• B. Trasferrin.
• C. Lactate.
• D. CRP.
• E. Transthretin.
12. BO5:10
• 10. Duplex ultrasound as diagnostic aid in mesenteric ischemia is
helpful best for:
• A. Acute mesenteric ischemia.
• B. Proximal disease.
• C. Distal disease.
• D. Chronic mesenteric ischemia.
• E. Obese patients.
13. BO5:11
• 11. The recommended imaging for the diagnosis of mesenteric
ischemic syndromes is:
• A. Duplex ultrasouns.
• B. CTA.
• C. MRA.
• D. Catheter angiography.
• E. Endoscopy.
14. BO5:12
• 12. The IVF volume requirements is more:
• A. Initially.
• B. In advanced disease.
• C. Before revascularization intervention.
• D. After revascularization intervention.
• E. None of the above.
15. BO5:13
• 13. Management of acute mesenteric ischemia include all except:
• A. IVF.
• B. Antibiotics.
• C. Vasodilators.
• D. Enteral feeding.
• E. Paranteral feeding.
16. BO5:14
• 14. The preferred approach for acute mesenteric ischemia is:
• A. Conservative management.
• B. Interventional radiology.
• C. Open surgery.
• D. Laproscopy surgery.
• E. None of the above.
17. BO5:15
• 15. The preferred approach for chronic mesenteric ischemia is:
• A. Conservative management.
• B. Interventional radiology.
• C. Open surgery.
• D. Laproscopy surgery.
• E. None of the above.
18. Introduction:
• Mesenteric ischemia is caused by blood flow insufficient to meet
the metabolic demands of the visceral organs.
• The severity & the type of organ involved depend on the affected
vessel& the extent of collateral-vessel blood flow.
• The most critical factor influencing outcomes is the speed of
diagnosis & intervention.
• Although uncommon cause of abdominal pain<1 of/1000 hospital
admissions, inaccurate or delayed diagnosis can result in
catastrophic complications & mortality among acute cases of 60-
80%.
19. Types:
• 1.Occlusive arterial disease: Arterial obstruction, most common;
acute &chronic forms.
• A. Acute mesenteric ischemia constitutes a surgical emergency:
• 1.Embolic occlusion in 40-50% of cases
• 2.Thrombotic occlusion of a previously stenotic mesenteric vessel in
20 -35%
• 3.Dissection or inflammation of the artery in <5%.
20. Types:
• B. Chronic mesenteric ischemia:
• 1.>90% related to progressive atherosclerotic disease of the origins
of the visceral vessels; treated with elective revascularization to
avert the risk of complications& death associated with the
development of acute ischemia.
• 2. Mesenteric venous thrombosis, accounts for 5-15%, results in
impaired venous outflow, visceral edema&abdominal pain,caused
by primary or idiopathic thrombosis& 90% of cases related to
thrombophilia, trauma, or local inflammation as pancreatitis,
diverticulitis, or inflammation or infection in the biliary system.
• Patients typically respond to anticoagulation in combination with
treatment for underlying local or systemic processes.
• Surgical intervention is reserved for patients who are critically ill or
whose condition is deteriorating; it is rarely required.
21. Types:
• 2. Non-occlusive mesenteric ischemia:
• it accounts for 5-15% of all cases of mesenteric ischemia,most often
associated with cardiac insufficiency or low-flow states after cardiac
surgery or hypovolemia or heart failure& hemodialysis.
• The mesenteric circulation is a high-resistance vascular bed in which
impaired regional perfusion owing to vasospasm can develop.
• The incidence of non-occlusive mesenteric ischemia may be
decreasing as awareness of the condition increases &supportive
therapies improve.
22.
23. Pathophysiology:
• Mesenteric Circulation:
• Extremely complex.
• 3 primary vessels — the celiac artery, superior mesenteric artery, &
inferior mesenteric artery — interconnect through collateral
networks between the visceral & non-visceral circulations.
• These interconnections ensure that the loss of a single vessel does
not lead to catastrophic malperfusion of the viscera.
• The acute occlusion of a single vessel (typically the superior
mesenteric artery) in acute mesenteric ischemia can result in
profound ischemia caused by the loss of blood flow through this key
vessel & its collateral vascular network.
• In chronic mesenteric ischemia, additional collateral networks
develop over time; symptoms often do not appear until occlusion of
two or more primary vessels occurs.
24. Pathophysiology:
• Causes of altered mesenteric circulation:
• Often obstruction or diminished blood flow , with resulting hypoxia.
• Vasodilatation is the initial response, but prolonged ischemia leads
to vasoconstriction, which can persist even after intestinal blood
flow returns to normal.
• This early injury primarily affects the intestinal mucosa&submucosa
potentially impairs mechanisms that prevent the translocation of
bacteria from the intestinal lumen.
• Sequence of events result in the activation of systemic
inflammatory pathways & ultimately worsened vasospasm, further
regional ischemia& more extensive injury to the bowel wall.
• Without intervention, the damage can progress to full-thickness
injury, infarction & death.
25. History & PE:
• In contrast to other vascular disorders, mesenteric ischemia
primarily affects women; > 70% are female.
• The physician should assess the patient’s records& the results of
the examination for any evidence of other atherosclerotic &
vascular diseases, including PAD, cerebrovascular,CAD,
&renovascular disease.
• Other pulmonary &CV conditions must be identified & managed,
since they are often coexisting &may limit the available options for
revascularization.
26. History & PE:
• Features of acute mesenteric ischemia:
• May initially present with classic “pain out of proportion to
examination,” with an epigastric bruit; many, however, do not.
• Others may have tenderness with palpation owing to peritoneal
irritation caused by full thickness bowel injury.
• In a patient with abdominal pain of acute onset, it is critical to
assess the possibility of atherosclerotic disease&potential sources
of an embolus, including a history of AF &AMI.
• Patient’s description of the history & symptoms can be unclear
because of changes in mental status, particularly if elderly.
• Patients with mesenteric venous compared with acute arterial
occlusion, present with a less abrupt onset of abdominal pain.
• Risk factors for venous thrombosis: H/O deep venous thrombosis,
cancer, CLD or PVT, recent abd surgery, inflammatory disease &
thrombophilia.
27. History & PE:
• Features of chronic mesenteric ischemia:
• Can present with a variety of symptoms, including abd pain, PP
pain, nausea or vomiting (or both), early satiety, diarrhea or
constipation(or both)&weight loss.
• A detailed inquiry into the abd pain &relationship to eating can be
enlightening.
• Abdominal pain 30 - 60 minutes after eating is common&often self-
treated with food restriction, resulting in weight loss &in extreme
situations, fear of eating, or “food fear.”
• PP Pain DD: biliary disease,peptic ulcer disease, pancreatitis,
diverticular disease, gastric reflux, irritable bowel
syndrome&gastroparesis.
28. History & PE:
• An extensive GE workup, including even cholecystectomy , OGD&
lower endoscopy —often negative ,carried out before the diagnosis.
• An important distinction: these alternatives do not involve weight
loss, whereas it is common in cases of mesenteric ischemia.
• Since older age &H/O smoking are common in these patients,
cancer is often considered& may delay the identification of chronic
mesenteric ischemia.
• Particularly in the case of elderly women with a history of weight
loss, dietary changes& systemic vascular disease, chronic
mesenteric ischemia must be seriously considered&evaluated
appropriately.
29. Lab:
• Most useful in acute mesenteric ischemia are the assessment of
fluid, electrolyte, ABB& evaluation for infection.
• Many present with acidosis due to dehydration&decreased intake.
• Lactic acidosis often indicates at least segmental, severe ischemia or
irreversible bowel injury¬ helpful to wait for evidence of
increasing serum lactate to proceed with further testing &
intervention would occur before lactic acidosis develops, with the
goal of saving additional intestine from full-thickness injury.
• A left shift neutrophils or high WBC may indicate full-thickness
injury to the bowel wall or ischemia with bacterial translocation.
• S. biomarkers not proved valuable for the early detection&no
clinically useful biomarkers, owing to the hepatic metabolism of
complex proteins secreted by the intestine.
• Nutritional status; albumin, transthyretin, transferrin, CRP, are the
only studies of value in cases of chronic mesenteric ischemia.
30. Imagings:
• Ultrasonography:
• Duplex U/S has a high degree of reliability & reproducibility, with
sensitivity/specificity of 85-90%.
• It is effective, low-cost, helpful in the assessment of the proximal
visceral vessels, but limited more distally.
• It is extremely operator dependent.
• Difficult to obtain in patients with obesity, bowel gas,heavy
calcification in the vessels,patients with acute mesenteric ischemia
because of the length of the study &abdominal pressure required;
so best reserved for the evaluation of patients with chronic
mesenteric ischemia& for monitoring after intervention.
31.
32. Imagings:
• CTA: hs 95-100% accuracy, the recommended imaging for the
diagnosis of visceral ischemic syndromes, its benefits:
• Imaging origins&length of the vessels obtained rapidly
• Indicate extent of stenosis or occlusion.
• The relationship to branch vessels.
• Aid in the assessment of options for revascularization.
• indicate potential sources of emboli.
• Shows other intra-abd structures&pathologies as the lack of
enhancement or thickening of bowel wall &mesenteric stranding.
• Shows pneumatosis, free intraabdominal air, portal venous gas.
• CTA should be performed with IV contrast &reconstruction of
images with thin axial images (1-3 mm).
• Sensitivity of CTA is not as high for venous thrombosis,but improved
with two-phase imaging to enhance visceral venous drainage
33.
34. Imagings:
• MRA: attractive option provide information about flow & avoid the
risks of radiation&use of contrast associated with CTA.
• It test takes longer to perform than CTA, lacks the necessary
resolution&can overestimate the degree of stenosis.
• Currently CTA imaging is almost always the preferred choice&its
advantages outweigh any risks.
35. Imagings:
• Endoscopy: most useful in diagnosing conditions other than
mesenteric ischemia as inflammatory&ischemic changes in the
stomach and proximal small bowel, rectum&right colon.
• Does not reach the majority of sections of the small bowel that are
most frequently involved in mesenteric ischemia.
• Only sensitive in identifying late changes, including infarction, but
lacks sensitivity / specificity in detecting more subtle ischemic
changes.
36. Imagings:
• Catheter angiography: usually for therapeutic intervention rather
than for diagnosis.
• Revascularization with selective catheterization of mesenteric
vessels, then single or complementary endovascular therapies,
including thrombolysis,angioplasty with or without stenting&
intraarterial vasodilation combined to restore blood flow.
• Angiography can also be used to confirm the diagnosis before open
abd exploration is undertaken.
37.
38. Management:IVF,Electrolytes
• Fluid&Electrolyte Management:
• Fluid resuscitation with isotonic crystalloid&blood as needed.
• Serial monitoring of electrolytes& acid–base status should be
performed& invasive hemodynamic monitoring should be
implemented early especially in acute mesenteric ischemia, in
whom severe metabolic acidosis & hyperkalemia can develop as a
result of infarction with the potential for rapid decompensation to a
SIR or progression to sepsis.
• In hemodynamic instability; carefully adjust fluid volume while
avoiding fluid overload &pressor agents only as a last resort.
• The fluid-volume requirement can be very high, especially after
revascularization, because of the extensive capillary leakage; as
much as 10-20 liters of crystalloid fluid may be required during the
first 24 hours after the intervention.
39. Management:IVF,Electrolytes
• Early Medical Therapy:
• Heparin should be initiated as soon as possible in patients who
have acute ischemia or an exacerbation of chronic ischemia.
• Vasodilators may play a role in care, particularly in combating
persistent vasospasm in patients with acute ischemia after
revascularization.
• Bacterial translocation & sepsis develop& the high risk of infection
among outweighs the risks of antibiotic use, and therefore broad-
spectrum antibiotics should be administered early.
• Oral intake should be avoided in patients with acute mesenteric
ischemia, since it can exacerbate intestinal ischemia.
• In chronic mesenteric ischemia, enteral nutrition (as long as it does
not cause pain) or parenteral nutrition should be considered in
order to improve perfusion by means of mucosal vasodilation & to
provide nutritional&immunologic benefits.
40. Management:interventions
• Acute Mesenteric Ischemia: Endovascular interventions successful
in 87%, in-hospital mortality lower than open surgery (36% v 50%).
• This strategy may be most appropriate for patients with ischemia
not severe &those who have severe coexisting conditions that place
them at high risk for complications&death with open surgery.
• Most often mechanical thrombectomy or angioplasty & stenting.
• Thrombolysis is safe/effective in treating both embolic &
thrombotic occlusions& an adjunct to remove the additional burden
of thrombus in patients without peritonitis,especially helpful in
restoring perfusion to occluded arterial branches.
• 31% who received endovascular therapy were spared laparotomy.
• If endovascular-only therapy is pursued, close monitoring is
compulsory&any clinical deterioration or peritonitis necessitates
operative exploration as emergency as 28-59% will ultimately
require bowel resection.
41. Management:interventions
• Acute Mesenteric Ischemia: Open Repair
• Emboli causing acute occlusion typically lodge within proximal SMA
have good response to surgical embolectomy.
• If embolectomy is unsuccessful, arterial bypass may be performed.
• If distal perfusion remains impaired, local intraarterial doses of
thrombolytic agents can be administered.
• A hybrid option, retrograde open mesenteric stenting, involves local
thromboendarterectomy& angioplasty, followed by retrograde
stenting,reduces the extent of surgery while allowing for direct
assessment of the bowel
• Short-term mortality after open revascularization ranges from 26-
65%, higher with renal insufficiency, older age, metabolic acidosis, a
longer duration of symptoms, and bowel resection at the time of a
second-look operation.
42. Management:interventions
• Chronic Mesenteric Ischemia:
• Revascularization is indicated for all symptomatic patients.
• Now with endovascular repair, used in 70-80% of initial procedures.
• Stenting is used most often.
• Open repair can be performed with the use of antegrade inflow or
retrograde inflow (from the iliac artery), with either a vein or
prosthetic conduit to bypass one or more vessels, depending on the
extent of disease.
• Hybrid procedures involving open access to the superior mesenteric
artery &retrograde stenting, are also options.
• Endovascular therapy is a very successful,minimally invasive
approach that provides initial relief of symptoms in up to 95% & has
a lower rate of serious complications than open repair.
43. Management:interventions
• Chronic Mesenteric Ischemia
• Despite these advantages, the use of endovascular techniques is
associated with lower rates of long-term patency &shorter time to
the return of symptoms,restenosis occurs in 40% & 20 - 50% will
require re-intervention.
• Open repair is associated with slower recovery & longer hospital
stays than endovascular repair.
• In most centers, endovascular therapy is considered to be first-line
therapy, particularly in patients with short, focal lesions,In contrast,
open repair may be a preferable option for younger, lower-risk
patients with a longer life expectancy.
44. Management:interventions
• Venous Mesenteric Ischemia
• Unless such treatment is contraindicated, all patients should
initially receive heparin transitioned to long-term oral coagulation
24 - 48 hours after stabilization of the acute condition.
• 5% deteriorate, need transhepatic & percutaneous mechanical
thrombectomy, thrombolysis,open intraarterial thrombolysis.
• Any evidence of peritonitis, stricture, or GIB should trigger an
exploratory laparotomy to assess for the possibility of bowel
necrosis &need for a second-look operation.
• The long-term mortality is heavily influenced by the underlying
cause of thrombosis; 30-day survival is 80%&5-year survival is 70%.
45. Management:interventions
• Nonocclusive Mesenteric Ischemia
• The outcomes depend on the management of the underlying cause;
overall mortality is 50-83%.
• The initial goal is to address hemodynamic instability to minimize
the use of systemic vasoconstrictors.
• Additional treatment may include systemic anticoagulation and the
use of vasodilators in patients who do not have bowel infarction.
• Catheter-directed infusion of vasodilatory&antispasmodic agents,
most commonly papaverine hydrochloride, can be used.
• Patients should be monitored closely by means of serial abdominal
examinations&open surgical exploration should be performed if
there is concern about the possibility of peritonitis.
46. Management:Follow-up
• Long-Term Care:
• Aggressive smoking-cessation measures, blood-pressure control&
statin.
• Lifelong preventive treatment with aspirin is recommended in all
patients who undergo endovascular or open repair.
• Patients who undergo endovascular repair should also receive
clopidogrel for 1 - 3 months after the procedure.
• Regardless of the type of repair performed, in patients with atrial
fibrillation, mesenteric venous thrombosis, or inherited or acquired
thrombophilia, oral anticoagulant therapy is indicated&should be
continued indefinitely or until the underlying cause of embolism or
thrombosis has resolved.
47. Management:Follow-up
• Long-Term Care:
• Nutritional status & body weight monitored in all patients who have
undergone an intervention for mesenteric ischemia.
• These patients may have prolonged ileus, food fear&require total
parenteral nutrition until full oral intake is possible.
• In bowel resection, diarrhea / malabsorption may occur.
• Extensive nutritional support, lifelong total parenteral nutrition, or
even evaluation for small-bowel transplantation may be required in
patients with persistent short-gut syndrome.
• Assessment:
• Lifelong repeated assessment of vascular patency is indicated.
Duplex ultrasonography should be performed every 6 months for
the first year after repair, then yearly thereafter.
48. Conclusion:
• Mesenteric ischemia is one of the least common causes of
abdominal pain, but associated with extremely high risk.
• Despite the variety of presentations & causes of mesenteric
ischemia, it always presents a diagnostic challenge&has the
potential for catastrophic, lifethreatening consequences.
• Early consideration&evaluation of this disease &underlying causes
in patients with abdominal pain are critical to timely diagnosis &
improved outcomes.
49. BO5:1
• 1. Abdominal pain due to mesenteric ischemia is
• A. Rare.
• B. Uncommon.
• C. Common.
• D. Very common.
• E. Not uncommon.
50. BO5:2
• 2. The mortality from acute mesenteric ischemia is:
• A. Rare.
• B. Uncommon.
• C. Common.
• D. Very common.
• E. Not uncommon.
51. BO5:3
• 3. The most common cause of mesenteric ischemia is:
• A. Acute throbosis.
• B. Acute embolism.
• C. Acute dissection.
• D. Chronic atherosclerotic occlusion.
• E. Venous thrombosis.
52. BO5:4
• 4. The sequence of events in pathophysiology of acute mesenteric
ischemia include all except:
• A. Initial Vasospasm.
• B. Intestinal bacterial translocation.
• C. Systemic inflammatory response.
• D. Vasoconstriction.
• E. Intestinal infarction.
53. BO5:5
• 5. Mesenteric ischemia differs from other major organs
atherosclerotic ischemias by being:
• A. More common.
• B. Less lethal.
• C. More common in females.
• D. Easier to be diagnosis.
• E. All of the above.
54. BO5:6
• 6. The abdominal pain of acute mesenteric ischemia have more
similar characteristics to:
• A. Acute appendisitis.
• B. Acute cholecystitis.
• C. Acute pancreatitis.
• D. Bud-Chiari syndrome.
• E. Splenic infarction.
55. BO5:7
• 7. The abdominal pain of acute mesenteric ischemia is characterized
by being:
• A. Proportional to physical findings.
• B. Out of proportion to physical findings.
• C. Aggravated by movements.
• D. Relieved by movements.
• E. Associated with fever.
56. BO5:8
• 8. Clues to acute mesenteric ischemia as a cause of acute abdominal
pain is the presence of:
• A. DVT.
• B. Recent abdominal surgery.
• C. AF &AMI.
• D. Presence of diagnosed thrombophilia.
• E. Male sex.
57. BO5:9
• 9. Clues to the chronic mesenteric ischemia as a cause of chronic
abdominal pain is the presence of all except:
• A. Immediate post-prandial pain.
• B. 30 mins post-prandial pain.
• C. Food fear.
• D. Weight loss.
• E. Female sex.
58. BO5:10
• 10. The serum marker suggesting severe acute mesenteric ischemia
is:
• A. Albumin.
• B. Trasferrin.
• C. Lactate.
• D. CRP.
• E. Transthretin.
59. BO5:10
• 10. Duplex ultrasound as diagnostic aid in mesenteric ischemia is
helpful best for:
• A. Acute mesenteric ischemia.
• B. Proximal disease.
• C. Distal disease.
• D. Chronic mesenteric ischemia.
• E. Obese patients.
60. BO5:11
• 11. The recommended imaging for the diagnosis of mesenteric
ischemic syndromes is:
• A. Duplex ultrasouns.
• B. CTA.
• C. MRA.
• D. Catheter angiography.
• E. Endoscopy.
61. BO5:12
• 12. The IVF volume requirements is more:
• A. Initially.
• B. In advanced disease.
• C. Before revascularization intervention.
• D. After revascularization intervention.
• E. None of the above.
62. BO5:13
• 13. Management of acute mesenteric ischemia include all except:
• A. IVF.
• B. Antibiotics.
• C. Vasodilators.
• D. Enteral feeding.
• E. Paranteral feeding.
63. BO5:14
• 14. The preferred approach for acute mesenteric ischemia is:
• A. Conservative management.
• B. Interventional radiology.
• C. Open surgery.
• D. Laproscopy surgery.
• E. None of the above.
64. BO5:15
• 15. The preferred approach for chronic mesenteric ischemia is:
• A. Conservative management.
• B. Interventional radiology.
• C. Open surgery.
• D. Laproscopy surgery.
• E. None of the above.